Infinium Pharmachem Limited (NSE:INFINIUM)
India · Delayed Price · Currency is INR 214.50
-0.50 (-0.23%)
Jan 23, 2026, 12:40 PM IST
Infinium Pharmachem Revenue
Infinium Pharmachem had revenue of 840.51M INR in the half year ending September 30, 2025, with 36.71% growth. This brings the company's revenue in the last twelve months to 1.57B, down -0.23% year-over-year. In the fiscal year ending March 31, 2025, Infinium Pharmachem had annual revenue of 1.56B with 14.78% growth.
Revenue (ttm)
1.57B
Revenue Growth
-0.23%
P/S Ratio
2.14
Revenue / Employee
10.89M
Employees
144
Market Cap
3.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.56B | 200.50M | 14.78% |
| Mar 31, 2024 | 1.36B | 214.34M | 18.76% |
| Mar 31, 2023 | 1.14B | 151.06M | 15.24% |
| Mar 31, 2022 | 991.19M | 443.60M | 81.01% |
| Mar 31, 2021 | 547.59M | 183.31M | 50.32% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.28B |
| NGL Fine-Chem | 4.08B |
| Anlon Healthcare | 1.44B |
| Kimia Biosciences | 1.26B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.20B |
| Shree Ganesh Remedies | 1.06B |
| Panchsheel Organics | 1.03B |